Overview of Fungi Classified as Risk Group 3 by the Japanese Society for Medical Mycology
Medical Mycology Journal · 2024
DOI: 10.3314/mmj.24.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Mycology Journal, 2024. Verfasst von Masato Tashiro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences. Hauptthemen laut MEDLINE: Mycoses. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences.
- Infection Control and Education Center, Nagasaki University Hospital.
- Department of Respiratory Medicine, Nagasaki University Hospital.
Zitieren
APA
Tashiro, M., Takazono, T., & Izumikawa, K. (2024). Overview of Fungi Classified as Risk Group 3 by the Japanese Society for Medical Mycology. Medical Mycology Journal. https://doi.org/10.3314/mmj.24.008
Vancouver
Tashiro M, Takazono T, Izumikawa K. Overview of Fungi Classified as Risk Group 3 by the Japanese Society for Medical Mycology. Medical Mycology Journal. 2024. doi:10.3314/mmj.24.008
BibTeX
@article{Tashiro2024,
author = {Tashiro, Masato and Takazono, Takahiro and Izumikawa, Koichi},
title = {Overview of Fungi Classified as Risk Group 3 by the Japanese Society for Medical Mycology},
journal = {Medical Mycology Journal},
year = {2024},
doi = {10.3314/mmj.24.008}
}
EUVIMED